Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Angewandte Chemie (International Ed. in English)|May 17, 2018
A Cocatalyst that Stabilizes a Hydride Intermediate during Photocatalytic Hydrogen Evolution over a Rhodium-Doped TiO2 NanosheetShintaro Ida, Kenta Sato, Tetsuya Nagata, et al.
Molecular Therapy. Nucleic Acids|June 13, 2022
Systemic DNA/RNA heteroduplex oligonucleotide administration for regulating the gene expression of dorsal root ganglion and sciatic nerveHidetoshi Kaburagi, Tetsuya Nagata, Mitsuhiro Enomoto, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 14, 2018
Angubindin-1 opens the blood-brain barrier in vivo for delivery of antisense oligonucleotide to the central nervous systemSatoshi Zeniya, Hiroya Kuwahara, Kaiichi Daizo, et al.
Molecular Therapy. Nucleic Acids|July 9, 2024
Favorable efficacy and reduced acute neurotoxicity by antisense oligonucleotides with 2',4'-BNA/LNA with 9-(aminoethoxy)phenoxazineTaiki Matsubayashi, Kotaro Yoshioka, Su Su Lei Mon, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 25, 2023
Preferential delivery of lipid-ligand conjugated DNA/RNA heteroduplex oligonucleotide to ischemic brain in hyperacute stageFuying Li, Keiko Ichinose, Satoru Ishibashi, et al.
Molecular Therapy. Nucleic Acids|April 9, 2024
Erratum: Favorable efficacy and reduced acute neurotoxicity by antisense oligonucleotides with 2',4' -BNA/LNA with 9-(aminoethoxy)phenoxazineTaiki Matsubayashi, Kotaro Yoshioka, Su Su Lei Mon, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2012
Bodywide skipping of exons 45-55 in dystrophic mdx52 mice by systemic antisense deliveryYoshitsugu Aoki, Toshifumi Yokota, Tetsuya Nagata, et al.
FEBS Letters|January 29, 2020
Highly efficient gene silencing in mouse brain by overhanging-duplex oligonucleotides via intraventricular routeSu Su Lei Mon, Kotaro Yoshioka, Chunyan Jia, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 13, 2025
Pharmacokinetics and protein binding of cholesterol-conjugated heteroduplex oligonucleotideYukitake Yoshioka, Syunsuke Yamamoto, Kosuke Kusamori, et al.
Pageof 8